Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Finance
Biopharmaceutical company reports first quarter financial results
May 31st, 2004
Tercica, Inc., (TRCA) announced the results of operations for the quarter ended March 31, 2004. The company reported a net loss of $7.7 million for the first quarter of 2004, compared to a net loss of $2.9 million for the same period in 2003. The company completed its initial public offering during the first quarter of 2004, selling 5,500,000 shares of common stock. Also during the first quarter, but closing in the second quarter, the company's underwriters exercised in full their over-allotment option for 825,000 additional shares of common stock. Total net proceeds received from the initial public offering, after deducting...
Source: Obesity & Diabetes Week (2004-05-31)
|
